OSTEOARTHRITIS SCIENCES INC has a total of 13 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Australia, Canada and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ALFACYTE LTD, SHANGHAI BIRDIE BIOTECH INC and DEFENSIN THERAPEUTICS APS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Canada | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Jimenez Pablo A | 4 |
#2 | Chipman Stewart | 4 |
#3 | Haimes Howard B | 4 |
#4 | Faulkner David John | 3 |
#5 | Campbell R Nelson | 3 |
#6 | Vasios George W | 3 |
#7 | Sharpe Thomas R | 3 |
#8 | Jacobson Alan R | 2 |
#9 | Oleksyszyn Jozef | 1 |
#10 | Oleksyszyn Josef | 1 |
Publication | Filing date | Title |
---|---|---|
EP0850055A2 | Protein tyrosine kinase inhibitors for treating osteoarthritis | |
US5597808A | Use of pseudopterosins for promoting wound healing | |
US5591740A | Use of debromohymenialdisine for treating osteoarthritis | |
US5646316A | Bile acid inhibitors of metalloproteinase enzymes |